Bevacizumab With or Without Interferon Alfa in Treating Patients With Metastatic Malignant Melanoma

Clinical trial NCT00026221 · COMPLETED

Trial details

NCT number: NCT00026221
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Melanoma Stage IV Skin Melanoma

Start date: 2001-11-01
Primary completion: 2013-11-01
Enrollment: 57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.